SCHEMBL5145582

SCHEMBL5145582

CCCCc1c[nH]c2cc(N)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.54
HTR1A P08908 9/20 0.54
HTR2C P28335 1/20 0.50
HTR1D P28221 7/20 0.49
HTR1B P28222 7/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
SLC6A4 P31645 1/20 0.48
CYP2C19 P33261 2/20 0.46
MAPT P10636 2/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14160299 0.87 HTR1A (0.65) HTR2AHTR1AHTR1DHTR1BMEN1
Hydrochloric Acid SCHEMBL27517910 0.86 HTR1A (0.68) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL398434 0.83 HTR2A (0.51) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL5484715 0.83 HTR2A (0.51) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL397322 0.80 HTR2A (0.50) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL5497322 0.80 HTR2A (0.50) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL13715930 0.80 HTR2A (0.61) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL24243686 0.80 HTR2A (0.67) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL14310876 0.79 CHRNB2 (0.68) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL1576211 0.79 HTR2A (0.68) HTR2AHTR1AHTR2CHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1974212-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH Vertex Pharmaceuticals Incorporated (US) 2008-10-01 EP disclosed
WO-2007075946-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 WO disclosed